| Dr John C Hughes, MD | |
|
5400 Mackinaw Rd, Saginaw, MI 48604-9515 | |
| (989) 583-5060 | |
| Not Available |
| Full Name | Dr John C Hughes |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 55 Years |
| Location | 5400 Mackinaw Rd, Saginaw, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437200920 | NPI | - | NPPES |
| 2094721 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | JH029544 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Saginaw, MI | Hospital |
| Scheurer Hospital | Pigeon, MI | Hospital |
| Hills & Dales General Hospital | Cass city, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Center Inc | 2769387778 | 380 |
News Archive
"South Africa's maternal mortality rate has quadrupled while most African countries have cut that crucial health indicator - from 150 to 625 deaths for each 100,000 live births between 1998 and 2007," according to the Associated Press, citing a new Human Rights Watch (HRW) report that used data from the South African government.
U.S. Secretary of State Hillary Clinton's November 8 speech at the NIH, in which she called for the creation of an "AIDS-free generation" through the use of combination prevention strategies, "could be more than just political lip-service: it may also shape the next several years of U.S. global health programming and funding, analysts say," PlusNews reports.
Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that data from the PROTECT II study will be presented by Jeffrey W. Moses, M.D., Director of Interventional Services at NewYork-Presbyterian Hospital/Columbia University - Cornell Medical Center, during the late-breaking registries and clinical trial update session at EuroPCR 2011 in Paris.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that clinical and preclinical data supporting the role of CAL-101, an oral, p110δ(delta) selective PI3K inhibitor in patients with hematologic malignancies, will be featured in two oral presentations at the upcoming 51st American Society of Hematology (ASH) Annual Meeting taking place in New Orleans, LA.
Researchers are developing a tiny electronic sensor that can be embedded into bandages and help medics heal wounds by "listening" to them.
› Verified 3 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972590412 PECOS PAC ID: 2769387778 Enrollment ID: O20031209000107 |
News Archive
"South Africa's maternal mortality rate has quadrupled while most African countries have cut that crucial health indicator - from 150 to 625 deaths for each 100,000 live births between 1998 and 2007," according to the Associated Press, citing a new Human Rights Watch (HRW) report that used data from the South African government.
U.S. Secretary of State Hillary Clinton's November 8 speech at the NIH, in which she called for the creation of an "AIDS-free generation" through the use of combination prevention strategies, "could be more than just political lip-service: it may also shape the next several years of U.S. global health programming and funding, analysts say," PlusNews reports.
Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that data from the PROTECT II study will be presented by Jeffrey W. Moses, M.D., Director of Interventional Services at NewYork-Presbyterian Hospital/Columbia University - Cornell Medical Center, during the late-breaking registries and clinical trial update session at EuroPCR 2011 in Paris.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that clinical and preclinical data supporting the role of CAL-101, an oral, p110δ(delta) selective PI3K inhibitor in patients with hematologic malignancies, will be featured in two oral presentations at the upcoming 51st American Society of Hematology (ASH) Annual Meeting taking place in New Orleans, LA.
Researchers are developing a tiny electronic sensor that can be embedded into bandages and help medics heal wounds by "listening" to them.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John C Hughes, MD 1447 N Harrison St, Saginaw, MI 48602-4727 Ph: (989) 583-6000 | Dr John C Hughes, MD 5400 Mackinaw Rd, Saginaw, MI 48604-9515 Ph: (989) 583-5060 |
News Archive
"South Africa's maternal mortality rate has quadrupled while most African countries have cut that crucial health indicator - from 150 to 625 deaths for each 100,000 live births between 1998 and 2007," according to the Associated Press, citing a new Human Rights Watch (HRW) report that used data from the South African government.
U.S. Secretary of State Hillary Clinton's November 8 speech at the NIH, in which she called for the creation of an "AIDS-free generation" through the use of combination prevention strategies, "could be more than just political lip-service: it may also shape the next several years of U.S. global health programming and funding, analysts say," PlusNews reports.
Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that data from the PROTECT II study will be presented by Jeffrey W. Moses, M.D., Director of Interventional Services at NewYork-Presbyterian Hospital/Columbia University - Cornell Medical Center, during the late-breaking registries and clinical trial update session at EuroPCR 2011 in Paris.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that clinical and preclinical data supporting the role of CAL-101, an oral, p110δ(delta) selective PI3K inhibitor in patients with hematologic malignancies, will be featured in two oral presentations at the upcoming 51st American Society of Hematology (ASH) Annual Meeting taking place in New Orleans, LA.
Researchers are developing a tiny electronic sensor that can be embedded into bandages and help medics heal wounds by "listening" to them.
› Verified 3 days ago
Jerry Xavier, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, 1100 Internal Medicine, Saginaw, MI 48602 Phone: 989-583-5826 | |
Ray Peter Mangulabnan, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3170 Hallmark Ct, Saginaw, MI 48603 Phone: 989-790-1275 Fax: 989-249-4199 | |
Shafia Beg, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 | |
Dr. Natasa Petreska, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7500 | |
Dr. Manoj Sharma, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4884 Berl Dr, Saginaw, MI 48604 Phone: 989-497-9395 Fax: 989-497-9599 | |
Minoo Khetarpal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1320 N Michigan Ave, Suite 4, Saginaw, MI 48602 Phone: 989-755-5500 Fax: 989-755-7860 | |
Christine I Rohr, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 Fax: 989-583-6915 |